SHELTON, CT / ACCESS Newswire / July 30, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the "Company"), and a clinical stage, leading global pioneer in the development ...

The global impact of coronavirus disease 2019 (Covid-19) extends beyond the acute phase of infection, presenting ongoing challenges for public health and clinical management. Some people continue to ...

A 61-year-old male patient experienced dysuria, followed by the development of a solitary erythematous macule in the gluteal ...